COEPW
Coeptis Therapeutics Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.01
+0.00%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-18.8%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Feb 13, 2026 | Calise Chris · director | A-Award | 3,250 | $0.00 |
| Feb 13, 2026 | Cogley Brian · officer: Chief Financial Officer | M-Exempt | 10,000 | $11 |
| Feb 13, 2026 | Cogley Brian · officer: Chief Financial Officer | A-Award | 12,500 | $0.00 |
| Feb 13, 2026 | Deschamps Philippe · director | M-Exempt | 5,700 | $11 |
| Feb 13, 2026 | Deschamps Philippe · director | A-Award | 3,250 | $0.00 |
| Feb 13, 2026 | Calise Chris · director | M-Exempt | 5,700 | $11 |
| Feb 13, 2026 | Mehalick David · director, 10 percent owner, officer: CEO and President | M-Exempt | 148,875 | $7.05 |
| Feb 13, 2026 | Mehalick David · director, 10 percent owner, officer: CEO and President | A-Award | 51,250 | $0.00 |
| Feb 13, 2026 | Cochran Christopher P. · director | M-Exempt | 5,700 | $11 |
| Feb 13, 2026 | Cochran Christopher P. · director | A-Award | 3,250 | $0.00 |
| Feb 13, 2026 | Yerace Daniel Alexander · director, officer: VP Operations | M-Exempt | 10,000 | $10 |
| Feb 13, 2026 | Yerace Daniel Alexander · director, officer: VP Operations | A-Award | 20,000 | $0.00 |
| Feb 13, 2026 | Salkind Gene · director | M-Exempt | 5,700 | $11 |
| Feb 13, 2026 | Salkind Gene · director | A-Award | 3,250 | $0.00 |
| Feb 13, 2026 | DeSilva Tara · director | M-Exempt | 5,700 | $11 |
| Feb 13, 2026 | DeSilva Tara · director | A-Award | 3,250 | $0.00 |
| Feb 13, 2026 | Sheehy Christine Elise · officer: VP Compliance and Secy | M-Exempt | 1,000 | $11 |
| Feb 13, 2026 | Sheehy Christine Elise · officer: VP Compliance and Secy | A-Award | 12,500 | $0.00 |
| Mar 10, 2025 | Deschamps Philippe · director | A-Award | 5,700 | $11 |
| Mar 6, 2025 | Cogley Brian · officer: Chief Financial Officer | A-Award | 10,000 | $11 |
| Mar 6, 2025 | Yerace Daniel Alexander · director, officer: VP of Operations | A-Award | 5,000 | $11 |
| Mar 6, 2025 | Sheehy Christine Elise · officer: VP Compliance and Secy | A-Award | 1,000 | $11 |
| Mar 6, 2025 | Salkind Gene · director | A-Award | 5,700 | $11 |
| Mar 6, 2025 | Mehalick David · director, 10 percent owner, officer: CEO and President | A-Award | 28,875 | $11 |
| Mar 6, 2025 | DeSilva Tara · director | A-Award | 5,700 | $11 |
| Mar 6, 2025 | Cochran Christopher P. · director | A-Award | 5,700 | $11 |
| Mar 6, 2025 | Calise Chris · director | A-Award | 5,700 | $11 |
| Jan 17, 2024 | Cogley Brian · officer: Chief Financial Officer | Purchase | 5,000 | $0.67 |
| Jan 16, 2024 | DeSilva Tara · director | Purchase | 1,800 | $0.58 |
| Jan 16, 2024 | DeSilva Tara · director | Purchase | 466 | $0.56 |
Institutional positioning
13F filings over the trailing two quarters
New 2Increased 1Reduced 2Sold out 9
| Filer | Action | Shares | Filed |
|---|---|---|---|
| RIVERNORTH CAPITAL MANAGEMENT, LLC | Unchanged | 147,970 | May 15, 2026 |
| METEORA CAPITAL, LLC | New Position | 114,873 | May 15, 2026 |
| WALLEYE TRADING LLC | Unchanged | 79,942 | May 11, 2026 |
| SKYVIEW INVESTMENT ADVISORS, LLC | Reduced | 50,122 | May 15, 2026 |
| TORONTO DOMINION BANK | Reduced | 44,737 | May 15, 2026 |
| UBS GROUP AG | Increased | 23,227 | May 5, 2026 |
| TWO SIGMA SECURITIES, LLC | New Position | 20,393 | May 15, 2026 |
| HUNTING HILL GLOBAL CAPITAL, LLC | Unchanged | 16,382 | May 15, 2026 |
| CLEAR STREET GROUP INC. | Unchanged | 4,894 | May 15, 2026 |
| WELLS FARGO & COMPANY/MN | Unchanged | 100 | Jul 8, 2026 |
| Clear Street Group Inc. | Sold Out | 0 | May 15, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
| METEORA CAPITAL, LLC | Sold Out | 0 | May 15, 2026 |
| WELLS FARGO & COMPANY/MN | Sold Out | 0 | Jul 8, 2026 |
| TWO SIGMA SECURITIES, LLC | Sold Out | 0 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Feb 13, 2026